$8.81
-1.2%Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
Last Annual Value
-57.78M
3-Year CAGR
-131%
5-Year CAGR
-106%
10-Year CAGR
-61%
| Company | Deferred Income Tax | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
![]() Neogen Corporation NASDAQ:NEOG | -57.78M | N/A | N/A | N/A | |
![]() NovoCure Limited NASDAQ:NVCR | 0.00 | N/A | N/A | N/A | |
![]() Zenas BioPharma, Inc. NASDAQ:ZBIO | 0.00 | N/A | N/A | N/A | |
![]() Kestra Medical Technologies, Ltd. NASDAQ:KMTS | 64.00K | N/A | N/A | N/A | |
![]() BioLife Solutions, Inc. NASDAQ:BLFS | 0.00 | N/A | N/A | N/A | |
![]() Azenta, Inc. NASDAQ:AZTA | -27.04M | N/A | N/A | N/A | |
![]() OPKO Health, Inc. NASDAQ:OPK | -15.00M | N/A | N/A | N/A | |
![]() CONMED Corporation NYSE:CNMD | 3.52M | 71.4% | 3.2% | N/A | |
![]() Upstream Bio, Inc. NASDAQ:UPB | 0.00 | N/A | N/A | N/A | |
![]() Intellia Therapeutics, Inc. NASDAQ:NTLA | 0.00 | N/A | N/A | N/A |
Continue your NEOG research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.